SARS-CoV-2 protein E
From Proteopedia
(Difference between revisions)
(9 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | <SX viewer='molstar' load='' size='340' side='right' caption='' scene=''> | + | <SX viewer='molstar' load='7k3g' size='340' side='right' caption='PDB-ID 7K3G: Solid state NMR struture' scene=''> |
- | + | __TOC__ | |
- | + | ||
==Overview== | ==Overview== | ||
The envelope (E) protein of Sars-CoV and Sars-CoV-2 is the smallest of the viruse’s structural proteins. It is an integral membrane protein embedded in the envelope, but also localized in the ER, golgi and ERGIC, once a host cell has been infected <ref name="rasmol1"> J. Nieto-Torres, M. DeDiego, E. Álvarez, J. Jiménez-Guardeño, J. Regla-Nava, M. Llorente, et al.: Subcellular location and topology of severe acute respiratory syndrome coronavirus envelope protein, Virology, 2011 </ref>. | The envelope (E) protein of Sars-CoV and Sars-CoV-2 is the smallest of the viruse’s structural proteins. It is an integral membrane protein embedded in the envelope, but also localized in the ER, golgi and ERGIC, once a host cell has been infected <ref name="rasmol1"> J. Nieto-Torres, M. DeDiego, E. Álvarez, J. Jiménez-Guardeño, J. Regla-Nava, M. Llorente, et al.: Subcellular location and topology of severe acute respiratory syndrome coronavirus envelope protein, Virology, 2011 </ref>. | ||
- | The structure of the envelope protein of Sars-CoV has so far only been modeled on | + | The structure of the envelope protein of Sars-CoV has so far only been modeled based on nuclear magnetic resonance (NMR) data. Yet, modeling the 3D structure of Sars-CoV-2 E protein turns out to be quite challenging. Only the amino acid sequence of Sars-CoV-2 E protein is known, yet. Hence, the structure and function of Sars-CoV-2 E protein can only be prdicted by comparison with the Sars-CoV E protein. |
Sequence alignements of the envelope proteins of both viruses, consisting of 76 amino acids in Sars-CoV and 75 amino acids in Sars-CoV-2 <ref name="rasmol2"> M. Bianchi, D. Benvenuto, M. Giovanetti, S. Angeletti, M. Ciccozzi, S. Pascarella: Sars-CoV-2 Envelope and Membrane proteins: differences from closely related proteins linked to cross-species transmission?, Preprint, 2020 </ref> <ref name="rasmol3"> D. Schoeman, B. Fielding: Coronavirus envelope protein: current knowlege, Virology Journal, 2019 </ref>, demonstrate a 91% sequence homology <ref name="rasmol2"/>. Functional and structural comparison of Sars-CoV-2 with the existing knowlege about Sars-CoV could provide a good prediction of the E protein’s role in causing Covid-19. | Sequence alignements of the envelope proteins of both viruses, consisting of 76 amino acids in Sars-CoV and 75 amino acids in Sars-CoV-2 <ref name="rasmol2"> M. Bianchi, D. Benvenuto, M. Giovanetti, S. Angeletti, M. Ciccozzi, S. Pascarella: Sars-CoV-2 Envelope and Membrane proteins: differences from closely related proteins linked to cross-species transmission?, Preprint, 2020 </ref> <ref name="rasmol3"> D. Schoeman, B. Fielding: Coronavirus envelope protein: current knowlege, Virology Journal, 2019 </ref>, demonstrate a 91% sequence homology <ref name="rasmol2"/>. Functional and structural comparison of Sars-CoV-2 with the existing knowlege about Sars-CoV could provide a good prediction of the E protein’s role in causing Covid-19. | ||
Line 18: | Line 17: | ||
Several posttranslational modifications are proven to modify the E protein of Sars-CoV and other viruses. Palmitoylation is the addition of palmitic acid to cystein residues increasing the protein’s hydrophobicity. Hence, palmitoylation of E assists in membrane association and anchoring. In addition, the modification is suggested to co-localize the virus to the golgi membrane by operating as an additional targeting sequence. | Several posttranslational modifications are proven to modify the E protein of Sars-CoV and other viruses. Palmitoylation is the addition of palmitic acid to cystein residues increasing the protein’s hydrophobicity. Hence, palmitoylation of E assists in membrane association and anchoring. In addition, the modification is suggested to co-localize the virus to the golgi membrane by operating as an additional targeting sequence. | ||
Ubiquitination assays with Sars-CoV E protein proves that its “ubiqutination status inversely correlates to its stability and half life”<ref name="rasmol3"/>. Accordingly, ubiquitination might function as a negative regulation of E protein levels and consequntly of viral production to achieve the best viral titre. | Ubiquitination assays with Sars-CoV E protein proves that its “ubiqutination status inversely correlates to its stability and half life”<ref name="rasmol3"/>. Accordingly, ubiquitination might function as a negative regulation of E protein levels and consequntly of viral production to achieve the best viral titre. | ||
- | Another modification shown to occure in Sars-CoV E protein adds oligiosaccharid fragments to asparagine residues in a certain motif (Asn-X-Ser/Thr) which is also involved in the sequence of Sars-CoV-2 envelope protein. This modification, namely glycosilation, recruits chaperone proteins of the host cell that aid in the correct folding of new synthesized viral proteins. In Sars-CoV residue N66 embedded in the motif Asn-Ser-Ser was discovered to be glycosilated, while | + | Another modification shown to occure in Sars-CoV E protein adds oligiosaccharid fragments to asparagine residues in a certain motif (Asn-X-Ser/Thr) which is also involved in the sequence of Sars-CoV-2 envelope protein. This modification, namely glycosilation, recruits chaperone proteins of the host cell that aid in the correct folding of new synthesized viral proteins. In Sars-CoV residue N66 embedded in the motif Asn-Ser-Ser was discovered to be glycosilated, while the other potential glycosilation target N48 also located in a suitable motif (Asn-Val-Ser) had no attached oligiosaccharid. Both motifs are also found in Sars-CoV-2. Experimantal data suggest that glycosilation of N66 might prevent oligiomerization of E to promote various processes induced by monomeric E protein <ref name="rasmol3"/>. |
==Function== | ==Function== | ||
Line 54: | Line 53: | ||
Still, according to predictions there are a lot more interacting partners of E that have not yet been uncovered. As it has already been demonstrated by the known interacting partners of E, PPIs play a crucial role in the pathogenesis. Consequently, further research is necessary to perceive more details about the triggered signalling pathways and to discover new interacting proteins. | Still, according to predictions there are a lot more interacting partners of E that have not yet been uncovered. As it has already been demonstrated by the known interacting partners of E, PPIs play a crucial role in the pathogenesis. Consequently, further research is necessary to perceive more details about the triggered signalling pathways and to discover new interacting proteins. | ||
- | + | == See also == | |
- | + | [[Coronavirus_Disease 2019 (COVID-19)]]<br> | |
- | + | [[SARS-CoV-2_virus_proteins]]<br> | |
- | + | [[COVID-19 AlphaFold2 Models]] | |
- | + | ||
</SX> | </SX> | ||
== References == | == References == | ||
<references/> | <references/> |
Current revision
|
References
- ↑ J. Nieto-Torres, M. DeDiego, E. Álvarez, J. Jiménez-Guardeño, J. Regla-Nava, M. Llorente, et al.: Subcellular location and topology of severe acute respiratory syndrome coronavirus envelope protein, Virology, 2011
- ↑ 2.0 2.1 2.2 M. Bianchi, D. Benvenuto, M. Giovanetti, S. Angeletti, M. Ciccozzi, S. Pascarella: Sars-CoV-2 Envelope and Membrane proteins: differences from closely related proteins linked to cross-species transmission?, Preprint, 2020
- ↑ 3.00 3.01 3.02 3.03 3.04 3.05 3.06 3.07 3.08 3.09 3.10 3.11 3.12 3.13 3.14 3.15 D. Schoeman, B. Fielding: Coronavirus envelope protein: current knowlege, Virology Journal, 2019
- ↑ 4.0 4.1 Y. Li, W. Surya, S. Claudine, J. Torres: Structure of a Conserved Golgi Complex-targeting Signal in Coronavirus Envelope Proteins, The Journal Of Biological Chemistry, 2014
- ↑ Y. Li, W. Surya, S. Claudine, J. Torres: Structure of a Conserved Golgi Complex-targeting Signal in Coronavirus Envelope Proteins, Journal of Biological Chemistry, 2014
- ↑ Y. Ye, B. Hogue: Role of the coronavirus E viroporin protein transmembrane domain in virus assembly, Virology Journal, 2007
- ↑ 7.0 7.1 K. Pervushin, E. Tan, K. Parthasarathy, X. Lin, F. Jiang, D. Yu, A. Vararattanavech, T. Soong, D. Liu, J. Torres: Structure and Inhibition of the SARS Coronavirus Envelope Protein Ion Channel, PloS Pathogens, 2009
- ↑ J. Nieto-Torres, M. DeDiego, C. Verdiá-Báguena, J. Jimenez-Guardeño, J. Regla-Nava, R. Fernandez-Delgado, et al.: Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis, PLoS Pathogens, 2014
- ↑ 9.0 9.1 J. Nieto-Torres, C. Verdiá-Báguena, J. Jimenez-Guardeño, J. Regla-Nava, C. Castaño-Rodriguez, R. Fernandez-Delgado, et al.: Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome, Virology, 2015
- ↑ E. Álvarez, M. DeDiego, J. Nieto-Torres, J. Jiménez-Guardeño, L. Marcos-Villar, L. Enjuanes: The envelope protein of severe acute respiratory syndrome coronavirus interacts with the non-structural protein 3 and is ubiquitinated, Virology, 2010
- ↑ Y. Yang, Z. Xiong, S. Zhang, Y. Yan, J. Nguyen, B. Ng, et al.: Bcl-xL inhibits T-cell apoptosis induced by expression of SARS coronavirus E protein in the absence of growth factors, Biochemical Journal, 2005
- ↑ K. Teoh, Y. Siu, W. Chan, M. Schlüter, C. Liu, J. Peiris, et al.: The SARS coronavirus E protein interacts with PALS1 and alters tight junction formation and epithelial morphogenesis, Mol Biol Cell, 2010
- ↑ O. Wittekindt: Tight junctions in pulmonary epithelia during lung inflammation, Springer Verlag, 2016
- ↑ J. Jimenez-Guardeño, J. Nieto-Torres, M. DeDiego, J. Regla-Nava, R. Fernandez-Delgado, C. Castaño-Rodriguez, et al.: The PDZ-binding motif of severe acute respiratory syndrome coronavirus envelope protein is a determinant of viral pathogenesis, PLoS Pathogens, 2014